Will New COVID-19 Vaccines Affect Risk Stratification?
Listen as expert faculty discuss new COVID-19 vaccines and how they may affect risk stratification of individuals infected with SARS-CoV-2.
Decera Clinical Education Infectious Disease Podcast · Fernando Carnavali MD, Renslow Sherer MD
Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Fernando Carnavali, MD; Renslow Sherer, MD; and Joseph Torrisi, PharmD, BCIDP, discuss how new COVID-19 vaccines may affect risk stratification, including:
- Omicron-specific vaccine
- Role of vaccination in risk stratification
Presenters:
Fernando Carnavali, MD
Associate Professor of Medicine
Division Chief
General Internal Medicine
Department of Medicine
Site Director
COVID Center of Excellence Satellite-Ansonia
Mount Sinai Health System
New York, New York
Renslow Sherer, MD
Director
International HIV Training Center
Professor of Medicine
Section of Infectious Diseases and Global Health
Department of Medicine
University of Chicago
Chicago, Illinois
Joseph Torrisi, PharmD, BCIDP
Clinical Pharmacy Specialist
Infectious Diseases
Pharmacy
Grady Health System
Atlanta, Georgia
Link to slides:
https://bit.ly/3WDYeFK
Link to full program:
https://bit.ly/3WJdIbs
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.